Who We Are
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.
Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.
About Technical Operations
BioMarin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff build and maintain BioMarin’s cutting-edge manufacturing processes and sites, provide quality assurance and quality control to ensure we meet regulatory standards, and procure the needed goods and services to support manufacturing and coordinating the worldwide movement of our drugs to patients.
Role Summary
The Manager, CTO Quality Management & Operations is responsible for GMP Quality oversight of Contract Testing Organizations (CTOs) that perform testing of BioMarin intermediates, drug substance/API, and drug product across the legacy BioMarin and Amicus portfolios. The role ensures external testing activities are executed in compliance with approved methods, regulatory filings, Quality Technical Agreements (QTAs), and BioMarin policies and procedures, with particular focus on method transfers, release testing oversight, and quality issue resolution at assigned CTOs.
The incumbent acts as a key Quality point of contact for assigned external testing partners and plays a pivotal role in ensuring effective communication and streamlined processes for outsourced QC testing. They partner cross-functionally with Analytical Sciences, Regulatory Affairs, Supply Chain, Procurement, and Site Quality to ensure external testing models remain compliant, sustainable, and aligned with BioMarin's QC Network Strategy.
Key Responsibilities
CTO Oversight:
Method Transfer & Lifecycle Management:
Quality Systems & Compliance
Cross Functional & Network Support
Qualifications
Approximately 10–20% domestic and international travel to CTOs, ICT partners, and BioMarin sites as required.
Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

Granicus

ClanX

Deutsche Telekom IT Solutions Slovakia

Mytigate GmbH

T-Tech

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.